This article has been updated from a previous version to add comments from Qiagen's Q1 earnings call.

NEW YORK (GenomeWeb) – Qiagen reported after the close of the market on Tuesday that its first quarter revenues rose 3 percent, bolstered by increases in sales from every business except instruments.

For the three months ended March 31, the company reported revenues of $307.7 million, up from $298.4 million a year ago, and beating the average Wall Street estimate of $306.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.